Melcalin® PRALBUMINA

melcalin

Net Weight: 532 g

Melcalin Pralbumina is a food supplement containing Proteins and Minerals. Proteins contribute to the growth and maintenance of muscle mass while minerals help electrolyte balance and the reduction of tiredness and fatigue.
Melcalin Pralbumina is gluten and lactose free.

Description:

PRALBUMINA is a food supplement based on proteins (egg white) and minerals. The product supplements the albumin properties to those of a very low PRAL (-35).
Albumin regulates and maintains the osmotic pressure necessary for the proper distribution of body fluids intra and extracellular (ECW-ICW), modulates vascular tone, regulates the acid-base balance, has antioxidant functions and scavenger, acts as a transport of hormones and toxic substances by acting as chelating of metals such as copper, zinc, cadmium, nickel and cobalt. These properties are integrated with those arising from the assumption of buffer elements (very negative value of PRAL-Potential Renal Acid Load) which are of considerable benefit for the maintenance of muscle mass (FFM Skeletal muscle, TBprotein) and skeletal (bone) and for the improvement of various problems in the cardio-vascular system load.

Nutritional info:

scheda_Melcalin_PRALBUMINA_ver_medica_rev1engl

Ingredients:

  • Egg protein,
  • Potassium citrate,
  • Magnesium citrate,
  • Calcium citrate,
  • Flavors,
  • Silicon dioxide (anti-caking agent),
  • Sucralose (sweetener).

Indications:

  • Block of the loss of lean mass (FFM) and an adjunct in the recovery of muscle mass (FFM Skeletal muscle),
  • Adjustment of the Oncotic pressure (distribution of intra- and extracellular fluids),
  • Adjustment of the acid-base balance,
  • Antioxidant action increase,
  • Transport of hormones,
  • Chelation action and transport of toxic substances.

Method of administration:

Dissolve 19 g of product, equal to 2 scoops in 350- 400 ml of water. Shake well to favor the dissolution of the product. Alternatively, use a shaker.

Storage instructions:

Store cool and dry place, away from heat or direct sunlight. The expiry date indicated refers to the product correctly stored in its undamaged package.

Important information:

Food supplements should not be used as a substitute for a varied diet and should be taken within a balanced and healthy lifestyle. Do not exceed the recommended dose. Keep out of sight and reach of children under 3 years of age. Dispose of container in accordance with regulation.

Bibliography:

  • Marjolaine Roche, Philippe Rondeau, Nihar Ranjan Singh, Evelyne Tarnus, Emmanuel Bourdon. The antioxidant properties of serum albumin. Flebs letters Volume 582, Issue 13, 11 June 2008, Pages 1783-1787
  • Philippe Rondeau, Emmanuel Bourdon. The glycation of albumin : Structural and functional impacts. Biochimie Volume 93, Issue 4, April 2011, Pages 645-658
  • Shaklai N, Garlick RL, Bunn HF. Nonenzymatic glycosylation of human serum albumin alters its conformation and function. J Biol Chem. 1984 Mar 25;259(6):3812-7.
  • Evans TW. Review article: albumin as a drug–biological effects of albumin unrelated to oncotic pressure. Aliment Pharmacol Ther. 2002 Dec;16 Suppl 5:6-11.
  • Silvia Martini, Claudia Bonechi, Mario Casolaro, Gianfranco Corbini, Claudio Rossi, –protein recognition processes investigated by NMR relaxation data: A study on corticosteroid – albumin interactions. Biochemical Pharmacology Volume 71, Issue 6, 14 March 2006, Pages 858-864
  • Marcel J.E. Fischer, Octaaf J.M. Bos, RenéF. van der Linden, Jaap Wilting, Lambert. H.M. Janssen Steroid binding to human serum albumin and fragments thereof: Role of protein conformation and fatty acid content. Biochemical Pharmacology Volume 45, Issue 12, 22 June 1993, Pages 2411-2416
  • Michael E Baker. Albumin ‘s role in steroid hormone action and the origins of vertebrates: is albumin an essential protein?. Flebs Letter Volume 439, Issues 1-2, 13 November 1998, Pages 9-12
  • Wojciech Bala, , John Christodouloub, Peter J. Sadlerc, Alan Tucker. Multi-metal binding site of serum albumin. Journal of Inorganic Biochemistry Volume 70, Issue 1, April 1998, Pages 33-39
  • Sakda T. Trisak, Prayong Doumgdee, Bernd M. Rode. Binding of zinc and cadmium to human serum albumin. International Journal of Biochemistry Volume 22, Issue 9, 1990, Pages 977-981
  • P. Bourassa, I. Hasni, H.A. Tajmir-Riahi. Folic acid complexes with human and bovine serum albumins. Food Chemistry Volume 129, Issue 3, 1 December 2011, Pages 1148-1155
  • Bernhard Kreymann , , Markus Seige, Ursula Schweigart, Klaus-Friedrich Kopp, Meinhard Classen. Albumin dialysis: effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: a new possibility for the elimination of protein-bound toxins. Journal of Hepatology Volume 31,
  • Issue 6, December 1999, Pages 1080-1085 Soko?owska M, Wszelaka-Rylik M, Pozna?ski J, Bal W. Spectroscopic and thermodynamic determination of three distinct binding sites for Co(II) ions in human serum albumin. J Inorg Biochem. 2009 Jul;103(7):1005-13. Epub 2009 May 3.
  • David Bar-Or, Leonard T. Rael, Raphael Bar-Or, Denetta S. Slone, Charles W. Mains, Nagaraja K.R. Rao, C. Gerald Curtis. The cobalt–albumin binding assay: Insights into its mode of action. Clinica Chimica Acta Volume 387, Issues 1-2, January 2008, Pages 120-127
  • Bruttomesso D, Iori E, Kiwanuka E, Zanetti M, Pianta A, Vettore M, Tiengo A, Tessari P. Insulin infusion normalizes fasting and post-prandial albumin and fibrinogen synthesis in Type 1 diabetes mellitus. Diabet Med. 2001 Nov;18(11):915-20.
  • Pierpaolo De Feo,t Margaret Gan Gaisano and Morey W. Haymond. Differential Effects of Insulin Deficiency on Albumin and Fibrinogen Synthesis in Humans.
  • J.Clin.Invest. Vol 88, Sept.1991, 833-840
  • Han J. Moshage, Hans J.W. de Haard, Hans M.G. Princen, Sing Hiem Yap. The influence of glucocorticoid on albumin synthesis and its messenger RNA in rat in vivo and in hepatocyte suspension culture. Biochimica et Biophysica Acta (BBA) – Gene Structure and Expression Volume 824, Issue 1, 29 January 1985, Pages 27-33
  • Chih-Dou Chou, Huey-Wen Yien, Der-Min Wu, Cheng-Deng Kuo, Albumin Administration in Patients with Severe Sepsis Due to Secondary Peritonitis. Journal of the Chinese Medical Association Volume 72, Issue 5, May 2009.
  • Basil T. Doumas, Theodore Peters Jr. Serum and urine albumin : a progress report on their measurement and clinical significance. Chimica Acta Volume 258, Issue 1, 3 February 1997, Pages 3-20
  • J.P.Nicholson, M.R.Wolmarans and G.R.Park. The role of albumin in critical illness. Oxforx Journals (2000) 85 (4): 599-610.
  • Philip Goldwasser, Joseph Feldman. Association of serum albumin and mortality risk. Journal of Clinical Epidemiology Volume 50, Issue 6, June 1997, Pages 693-703
  • Zhang L, Curhan GC, Forman JP. Diet-dependent net acid load and risk of incident hypertension in United States women. Hypertension. 2009 Oct;54(4):751-5. Epub 2009 Aug 10.
  • Dargent-Molina P, Sabia S, Touvier M, Kesse E, Bréart G, Clavel-Chapelon F, Boutron-Ruault MC. Proteins, dietary acid load, and calcium and risk of postmenopausal fractures in the E3N French women prospective study. J Bone Miner Res. 2008 Dec;23(12):1915-22.
  • Murakami K, Sasaki S, Takahashi Y, Uenishi K. Association between dietary acid-base load and cardiometabolic risk factors in young Japanese women. Br J Nutr. 2008 Sep;100(3):642-51. Epub 2008 Feb 18.
  • Zwart SR, Davis-Street JE, Paddon-Jones D, Ferrando AA, Wolfe RR, Smith SM. Amino acid supplementation alters bone metabolism during simulated weightlessness. J Appl Physiol. 2005 Jul;99(1):134-40. Epub 2005 Feb 3.